Cyclica Overview
Company Headquarters: Toronto, Canada
Founded: 2013
Workforce: 200
Company Working: Cyclica is a data-driven drug discovery company. The company’s calculation method for polypharmacology is unique in the industry. Cyclica used a proteome-wide lens to measure novel and off-target interaction instantaneously. The company offers its product and services under the category of drug development, network pharmacology, drug repositioning, proteomics, clinical trials, side effects, bioinformatics, systems biology, drug discovery, artificial intelligence, polypharmacology, medicines, machine learning, pharmacology, pharmaceuticals, and bioinformatics. The company has a strong business presence in Canada.
Strategy
Cyclica is focused on providing Artificial Intelligence (AI) to make drug discovery faster, safer, and cheaper. The company enhances the technology AI in drug discovery for providing the best services to customers. It also strategizes on expanding the value of ligand expression downstream to examine the impact that genetic differences have on protein structure, and hence gaining insight into structural pharmacogenomics.
